Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 1 16Phase NA 5Phase 1/2 5Phase 3 4Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Completed 5Recruiting 4Active not recruiting 3Terminated 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Endocrine 4Head & Neck 3CNS 2Thoracic 1

Conditions

Breast Neoplasms 1911Neoplasms 1531Prostatic Neoplasms 753Colorectal Neoplasms 715Lung Neoplasms 583Motor Activity 393Head and Neck Neoplasms 328Colonic Neoplasms 312Uterine Cervical Neoplasms 300Pain 248Pancreatic Neoplasms 246Anxiety Disorders 221Rectal Neoplasms 214Carcinoma, Hepatocellular 209Carcinoma, Non-Small-Cell Lung 206Fatigue 194Stomach Neoplasms 192Polycystic Ovary Syndrome 188Ovarian Neoplasms 186Precursor Cell Lymphoblastic Leukemia-Lymphoma 178Brain Neoplasms 169Depression 166Urinary Bladder Neoplasms 165Melanoma 163Neoplasm Metastasis 162Esophageal Neoplasms 140Multiple Myeloma 138Lymphoma 136Lymphoma, Follicular 128Obesity 127

Interventions

lenvatinib 1fluorodopa F 18 1cabozantinib 1Restraint, Physical 1Gefitinib 1Ferrosoferric Oxide 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Completed × Carcinoma, Medullary × Clear all
NCT02856347 2025-11-18

CMTpostopFDOPA

Institut Claudius Regaud

Phase NA Completed
24 enrolled

Carcinoma, Medullary

NCT05534594 2025-06-24

MIMETIC

University Medical Center Groningen

Phase NA Completed
8 enrolled
EndocrineHead & Neck

Thyroid cancer, medullary, Thyroid Neoplasms, Carcinoma, Medullary

NCT02592356 2024-03-05

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

M.D. Anderson Cancer Center

Phase NA Completed
23 enrolled
CNSEndocrine

Paraganglioma, Extra-Adrenal, Carcinoma, Medullary

NCT01927887 2017-06-06

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

Massachusetts General Hospital

Phase NA Completed
12 enrolled 6 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary, Carcinoma, Medullary

NCT00068497 2013-01-14

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase NA Completed
40 enrolled
CNSEndocrineHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Parathyroid Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Tongue Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡